WHO Foundation, Lilly Partner to Advance Global Dementia Care
The WHO Foundation and Lilly have announced a collaboration to financially support the aims of the World Health Organization’s global action plan on the public...
Category : Healthcare and Pharmaceutical
Alamar Launches NULISAqpcr™ BD-pTau217 Assay for Alzheimer’s
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. Alamar Biosciences, a company powering precision proteomics to enable...
Aetna Hits 81% Medicare Advantage 4-Star Member Goal for 2026
Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug...
Seegene & Springer Nature Open Applications for 2025-2026 Grants
– The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026– Selected...
Renalys Completes Data Collection for Sparsentan Phase III Trial
Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys”) announced today that it has completed data collection for the primary endpoint in the Phase III clinical trial...
Berlin Heals Completes Phase I Enrollment for CMIC-III Study
Berlin Heals Holding AG, a leading clinical-stage medical device company focused on revolutionizing the care of Heart Failure with a first of its kind durable...
Infinitus Teams with Cisco’s Outshift to Boost AI Agent Trust
Infinitus Systems, healthcare’s leading agentic communications partner powering more than 100 million minutes of clinical and administrative conversations, today announced that the company has partnered...
Croma-Pharma Partners with Renellence for Canada Distribution
Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced a new distribution partnership with Renellence, a Canadian company specializing in aesthetic medicine....
Astria Therapeutics Starts Phase 3 ORBIT-EXPANSE Trial
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced the initiation of the Phase 3 ORBIT-EXPANSE...
GeneDx to Present Research at ASHG Annual Meeting
With unmatched scale and diversity, GeneDx Infinity™ powers scientific discovery while enabling the most precise clinical rare disease diagnoses for patients and families today GeneDx...
Aarvik Therapeutics Gets Investment from Laurus Labs Seed Round
Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce an investment by Laurus Labs, India in Aarvik’s recently-concluded...
Kiel Laboratories Gets 16th New Drug Application Approval
Kiel Laboratories, a leading strategic consulting and pharmaceutical services provider, announced the successful approval of its 16th New Drug Application (NDA) through the U.S. Food...
MedTech Innovator Reveals 2025 Grand Prize & Award Winners
—Armor Medical wins $350,000 Grand Prize to advance maternal aRMOR, non-invasive, real-time monitoring to detect early hemorrhage, empowering healthcare providers to save lives, enhance workflow...
Takara Bio USA Launches New Spatial Tech for Archival Samples
New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc....
bioAffinity Technologies Announces $1.8M Nasdaq Direct Financing
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it...